| Rapid spine delivery and redistribution of AMPA receptors after synaptic NMDA receptor activation SH Shi, Y Hayashi, RS Petralia, SH Zaman, RJ Wenthold, K Svoboda, ... Science 284 (5421), 1811-1816, 1999 | 1661 | 1999 |
| Regulation of synaptic strength and AMPA receptor subunit composition by PICK1 A Terashima, L Cotton, KK Dev, G Meyer, S Zaman, F Duprat, JM Henley, ... Journal of Neuroscience 24 (23), 5381-5390, 2004 | 224 | 2004 |
| Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study J Fortea, E Vilaplana, M Carmona-Iragui, B Benejam, L Videla, I Barroeta, ... The Lancet 395 (10242), 1988-1997, 2020 | 220 | 2020 |
| The pattern of amyloid accumulation in the brains of adults with Down syndrome T Annus, LR Wilson, YT Hong, J Acosta–Cabronero, TD Fryer, ... Alzheimer's & Dementia 12 (5), 538-545, 2016 | 174 | 2016 |
| Brain-predicted age in Down syndrome is associated with beta amyloid deposition and cognitive decline JH Cole, T Annus, LR Wilson, R Remtulla, YT Hong, TD Fryer, ... Neurobiology of aging 56, 41-49, 2017 | 137 | 2017 |
| Alzheimer's disease associated with Down syndrome: a genetic form of dementia J Fortea, SH Zaman, S Hartley, MS Rafii, E Head, M Carmona-Iragui The Lancet Neurology 20 (11), 930-942, 2021 | 122 | 2021 |
| The early presentation of dementia in people with Down syndrome: a systematic review of longitudinal studies BA Lautarescu, AJ Holland, SH Zaman Neuropsychology review 27, 31-45, 2017 | 110 | 2017 |
| Sequence of a functional invertebrate GABAA receptor subunit which can form a chimeric receptor with a vertebrate alpha subunit. RJ Harvey, E Vreugdenhil, SH Zaman, NS Bhandal, PN Usherwood, ... The EMBO Journal 10 (11), 3239-3245, 1991 | 108 | 1991 |
| Women with autistic-spectrum disorder: magnetic resonance imaging study of brain anatomy M Craig, SH Zaman, EM Daly, WJ Cutter, DMW Robertson, B Hallahan, ... The British Journal of Psychiatry 191 (3), 224-228, 2007 | 90 | 2007 |
| Neuroprotective effect of TREM-2 in aging and Alzheimer’s disease model AA Raha, JW Henderson, SRW Stott, R Vuono, S Foscarin, RP Friedland, ... Journal of Alzheimer's Disease 55 (1), 199-217, 2017 | 88 | 2017 |
| Effects of subunit types of the recombinant GABAA receptor on the response to a neurosteroid SH Zaman, R Shingai, RJ Harvey, MG Darlison, EA Barnard European Journal of Pharmacology: Molecular Pharmacology 225 (4), 321-330, 1992 | 86 | 1992 |
| Alzheimer's disease in Down syndrome: An overlooked population for prevention trials A Strydom, A Coppus, R Blesa, A Danek, J Fortea, J Hardy, J Levin, ... Alzheimer's & Dementia: Translational Research & Clinical Interventions 4 …, 2018 | 84 | 2018 |
| Neuroimaging and other modalities to assess Alzheimer's disease in Down syndrome N Neale, C Padilla, LM Fonseca, T Holland, S Zaman NeuroImage: Clinical 17, 263-271, 2018 | 78 | 2018 |
| Phosphatidylinositol 3 kinase regulates synapse specificity of hippocampal long-term depression MI Daw, ZA Bortolotto, E Saulle, S Zaman, GL Collingridge, JTR Isaac Nature neuroscience 5 (9), 835-836, 2002 | 76 | 2002 |
| Enhanced synaptic potentiation in transgenic mice expressing presenilin 1 familial Alzheimer's disease mutation is normalized with a benzodiazepine SH Zaman, A Parent, A Laskey, MK Lee, DR Borchelt, SS Sisodia, ... Neurobiology of disease 7 (1), 54-63, 2000 | 75 | 2000 |
| Further understanding the connection between Alzheimer's disease and Down syndrome HM Snyder, LJ Bain, AM Brickman, MC Carrillo, AJ Esbensen, ... Alzheimer's & Dementia 16 (7), 1065-1077, 2020 | 73 | 2020 |
| Using positron emission tomography and carbon 11–labeled pittsburgh compound B to image brain fibrillar β-amyloid in adults with Down syndrome: safety, acceptability, and … J Landt, JC D'Abrera, AJ Holland, FI Aigbirhio, TD Fryer, R Canales, ... Archives of Neurology 68 (7), 890-896, 2011 | 73 | 2011 |
| Introduction of green fluorescent protein (GFP) into hippocampal neurons through viral infection R Malinow, Y Hayashi, M Maletic-Savatic, SH Zaman, JC Poncer, SH Shi, ... Cold Spring Harbor Protocols 2010 (4), pdb. prot5406, 2010 | 67 | 2010 |
| The Down syndrome brain in the presence and absence of fibrillar β-amyloidosis T Annus, LR Wilson, J Acosta-Cabronero, A Cardenas-Blanco, YT Hong, ... Neurobiology of aging 53, 11-19, 2017 | 65 | 2017 |
| Alzheimer’s disease in people with Down’s syndrome: the prospects for and the challenges of developing preventative treatments P Castro, S Zaman, A Holland Journal of neurology 264 (4), 804-813, 2017 | 64 | 2017 |
